hepat
sinusoid
endotheli
cell
uniqu
among
endotheli
cell
abil
intern
process
divers
rang
antigen
dcsignr
type
ctype
lectin
express
liver
sinusoid
shown
bind
high
affin
hepat
c
viru
hcv
glycoprotein
dcsign
close
relat
homologu
report
express
dendrit
cell
subset
macrophag
similar
bind
affin
hcv
glycoprotein
receptor
function
adhes
antigen
present
molecul
report
distinct
pattern
dcsignr
dcsign
express
human
liver
tissu
show
first
time
ctype
lectin
express
sinusoid
endotheli
cell
confirm
receptor
function
demonstr
abil
bind
hcv
glycoprotein
although
lectin
primari
sinusoid
cell
support
hcv
bind
unabl
support
hcv
entri
data
support
model
dcsign
dcsignr
sinusoid
endothelium
provid
mechan
high
affin
bind
circul
hcv
within
liver
sinusoid
allow
subsequ
transfer
viru
underli
hepatocyt
manner
analog
dcsign
present
human
immunodefici
viru
dendrit
cell
hepat
sinusoid
endotheli
cell
uniqu
among
endotheli
cell
abil
intern
process
divers
rang
antigen
dcsignr
type
ctype
lectin
express
liver
sinusoid
shown
bind
high
affin
hepat
c
viru
hcv
glycoprotein
dcsign
close
relat
homologu
report
express
dendrit
cell
subset
macrophag
similar
bind
affin
hcv
glycoprotein
receptor
function
adhes
antigen
present
molecul
report
distinct
pattern
dcsignr
dcsign
express
human
liver
tissu
show
first
time
ctype
lectin
express
sinusoid
endotheli
cell
confirm
receptor
function
demonstr
abil
bind
hcv
glycoprotein
although
lectin
primari
sinusoid
cell
support
hcv
bind
unabl
support
hcv
entri
data
support
model
dcsign
dcsignr
sinusoid
endothelium
provid
mechan
high
affin
bind
circul
hcv
within
liver
sinusoid
allow
subsequ
transfer
viru
underli
hepatocyt
manner
analog
dcsign
present
human
immunodefici
viru
dendrit
cell
collectin
compris
famili
calciumdepend
patternrecognit
lectin
bind
oligosaccharid
structur
surfac
microorgan
facilit
clearanc
aggreg
complement
lysi
opson
two
member
famili
dcsign
relat
molecul
dcsignr
lsign
extens
studi
abil
bind
varieti
viral
pathogen
inde
molecul
often
refer
viral
attach
factor
potenti
infect
virus
dcsign
report
express
subset
macrophag
dendrit
cell
wherea
dcsignr
express
endotheli
cell
within
liver
sinusoid
lymph
node
dcsign
promot
cellular
uptak
present
antigen
potenti
interact
dcsignexpress
cell
leukocyt
via
interact
intercellular
adhes
recent
biochem
structur
studi
suggest
dcsign
dcsignr
differ
physiolog
function
distinct
ligandbind
properti
hepat
c
viru
hcv
envelop
positivestrand
rna
viru
sole
member
hepaciviru
genu
within
famili
flavivirida
approxim
million
individu
infect
worldwid
major
risk
develop
progress
liver
diseas
cellular
humor
immun
respons
gener
hcv
infect
major
individu
humor
immun
respons
ineffici
effect
viral
clearanc
new
infect
becom
chronic
liver
thought
primari
reservoir
support
hcv
replic
although
studi
hcv
cell
entri
tropism
limit
due
technic
difficulti
propag
infecti
hcv
cell
cultur
howev
recent
develop
infecti
retrovir
pseudotyp
bear
hcv
glycoprotein
hcvpp
robust
replic
hcv
strain
jfh
cell
cultur
hcvcc
enabl
studi
hcv
cell
entri
hcvpp
hcvcc
show
restrict
tropism
human
liver
cell
line
infect
depend
express
other
demonstr
hcvpp
interact
dcsignand
dcsignrexpress
cell
howev
physiolog
relev
viruslectin
interact
hcv
infect
liver
remain
unclear
hepat
sinusoid
endotheli
cell
hsec
uniqu
among
endotheli
cell
abil
intern
process
divers
rang
antigen
contrast
endotheli
cell
hsec
process
present
antigen
naiv
cell
cross
prime
cell
latter
respons
may
lead
antigenspecif
toler
rather
immun
suggest
hsec
may
contribut
tolerogen
properti
liver
particular
relev
set
hcv
infect
one
consid
chronic
natur
appar
ineffect
cellular
immun
respons
singl
report
dcsign
express
brain
microvascular
endotheli
cell
support
model
dcsign
may
express
hsec
contribut
uniqu
antigenpres
capabl
regul
immun
respons
pathogen
enter
liver
report
distinct
pattern
dcsignr
dcsign
express
human
liver
tissu
show
ctype
lectin
express
hsec
confirm
receptor
function
demonstr
abil
bind
hcv
protein
show
stimul
isol
hsec
increas
express
dcsign
dcsignr
promot
hcv
bind
howev
isol
hsec
support
hcvpp
hcvcc
infect
suggest
express
receptor
suffici
render
cell
permiss
hcv
infect
express
dcsign
hsec
may
allow
intern
antigen
includ
hcv
particl
subsequ
process
present
cell
interact
result
ineffect
tcell
activ
toler
may
contribut
fail
immun
respons
hcv
infect
ethic
approv
studi
given
south
birmingham
local
research
ethic
committe
queen
elizabeth
hospit
birmingham
uk
univers
hospit
birmingham
trust
queen
elizabeth
hospit
liver
tissu
collect
inform
consent
liver
tissu
nondiseas
liver
use
immunohistochem
studi
nondiseas
liver
obtain
either
patient
undergo
hemihepatectomi
remov
liver
metastas
organ
donor
liver
tissu
use
transplant
liver
endotheli
cell
isol
human
liver
tissu
surplu
surgic
requir
previous
describ
use
modifi
collagenas
digest
techniqu
briefli
nonparenchym
cell
separ
densiti
gradient
centrifug
metrizamid
sigmaaldrich
st
loui
mo
endotheli
cell
isol
result
heterogen
cell
mixtur
posit
immunomagnet
select
use
antibodi
gml
dako
eli
uk
dynabead
conjug
goatantimous
monoclon
antibodi
dynal
biotech
wirral
uk
accord
manufactur
protocol
follow
isol
hsec
cultur
complet
medium
compos
human
endotheli
basal
growth
medium
invitrogen
carlsbad
ca
ab
human
serum
hd
suppli
glasgow
uk
ngml
vascular
endotheli
growth
factor
ngml
hepatocyt
growth
factor
r
system
minneapoli
mn
cell
propag
collagenco
cultur
flask
maintain
humidifi
co
incub
cell
confluent
follow
primari
antibodi
use
dcsign
dcsignr
r
system
gift
david
jackson
univers
oxford
abcam
cambridg
uk
mannos
receptor
serotec
ltd
oxford
uk
cryostat
section
deriv
normal
liver
fix
aceton
minut
stain
use
standard
alkalin
phosphatas
antialkalin
phosphatas
techniqu
briefli
primari
antibodi
follow
rabbit
antimous
monoclon
mous
monoclon
alkalin
phosphatas
antialkalin
phosphatas
dako
stain
develop
fast
red
naphthol
asmx
phosphat
substrat
sigmaaldrich
section
dual
immunofluoresc
prewet
stain
buffer
phosphatebuff
salin
contain
fetal
calf
serum
sodium
azid
minut
slide
incub
primari
antibodi
dilut
stain
buffer
hour
humidifi
chamber
control
section
incub
isotypematch
r
system
section
stain
goat
antimous
alexa
fluor
molecular
probe
eugen
goat
antimous
fluorescein
isothiocyan
serotec
immunofluoresc
assess
use
axiovis
softwar
carl
zeiss
microimag
inc
jena
germani
hsec
plate
ml
grown
confluenc
collagenco
flat
bottom
plate
bd
falcon
oxford
uk
cell
left
basal
condit
stimul
cytokin
hour
ngml
recombin
tumor
necrosi
ngml
recombin
peprotech
london
uk
follow
stimul
cell
monolay
fix
methanol
nonspecif
bind
monoclon
antibodi
mab
inhibit
preincub
cell
hour
goat
serum
sigma
addit
mouseantihuman
mab
dcsign
dcsignr
gml
r
system
eselectin
gml
gml
dako
cell
wash
thoroughli
incub
peroxidaseconjug
goatantimous
secondari
ab
dako
enzymelink
immunosorb
assay
develop
use
ophenylenediamin
substrat
dako
accord
manufactur
instruct
enzymat
reaction
stop
use
moll
h
fisher
scientif
leicestershir
uk
colorimetr
analysi
perform
measur
absorb
valu
nm
use
mrx
plate
reader
dynatech
laboratori
sussex
uk
treatment
perform
triplic
experi
cell
transient
transfect
plasmid
express
vector
alon
control
mock
antigen
lipofectamin
invitrogen
accord
manufactur
instruct
tissu
cultur
supernat
contain
harvest
hour
transfect
amount
antigen
quantifi
enzym
immunoassay
describ
previous
normal
liver
section
preincub
isotypematch
control
block
dcsign
dcsignr
gml
r
system
mannan
gml
sigmaaldrich
hour
wash
incub
mock
antigen
satur
concentr
phosphatebuff
fetal
bovin
sodium
mmoll
cacl
hour
room
temperatur
wash
label
rat
mab
recogn
site
henc
fail
interact
complex
detect
bind
normal
liver
section
describ
use
immunofluoresc
goat
antirat
fluorescein
isothiocyan
serotec
immunofluoresc
assess
use
axiovis
softwar
carl
zeiss
microimag
inc
hsec
dissoci
flask
use
trypsin
invitrogen
wash
preincub
human
immunoglobulin
block
fc
receptor
hcv
bind
block
assay
describ
cell
fix
paraformaldehyd
sigmaaldrich
wash
resuspend
phosphatebuff
salin
fetal
calf
serum
analysi
epic
xl
flow
cytomet
beckman
coulter
fullerton
ca
use
summit
softwar
dakocytom
glostrup
denmark
hcv
pseudoparticl
hcvpp
gener
previous
describ
briefli
cell
cotransfect
plasmid
express
strain
h
vesicular
stomat
viru
g
protein
use
lipofectamin
invitrogen
medium
replac
dulbecco
modifi
eagl
fetal
bovin
serum
hour
pseudoparticlecontain
supernat
collect
hour
clarifi
low
speed
centrifug
minut
infect
experi
target
cell
plate
plate
per
well
hour
infect
pseudoparticlecontain
supernat
dilut
dulbecco
modifi
eagl
fetal
bovin
serum
gml
polybren
without
desir
lipoprotein
speci
mixtur
incub
hour
appli
target
cell
hour
pseudoparticl
remov
cell
incub
hour
cell
lyse
l
cell
cultur
lysi
reagent
promega
madison
wi
infect
measur
quantifi
luciferas
report
gene
addit
l
luciferas
substrat
promega
use
centro
luminomet
berthold
technolog
bad
wildbad
germani
huh
cell
trypsin
harvest
centrifug
g
minut
wash
twice
resuspend
icecold
phosphatebuff
salin
cellsml
one
microgram
rna
mix
ml
cell
gap
cuvett
puls
use
btx
electrosquarepor
harvard
apparatu
hollist
describ
previous
elec
tropor
cell
allow
recov
minut
room
temperatur
addit
complet
media
plate
diamet
cell
cultur
dish
hour
viru
contain
supernat
harvest
viral
stock
store
cell
infect
multipl
infect
cell
maintain
cultur
day
frequenc
hcvinfect
cell
cultur
investig
stain
cell
express
previous
describ
persist
infect
cultur
mix
primari
hsec
cultur
hour
stain
hcv
express
hsec
isol
human
liver
tissu
propag
cell
cultur
shown
intern
acetyl
low
densiti
lipoprotein
previous
describ
monoclon
antibodi
specif
dcsign
dcsignr
bound
cultur
cell
figur
b
appropri
isotypematch
control
neg
stain
shown
dcsign
express
monocyt
differenti
depend
cytokin
microenviron
determin
whether
cytokin
similarli
regul
dcsign
dcsignr
express
hsec
cell
treat
variou
cytokin
hour
lectin
express
measur
quantit
cellbas
immunoassay
significantli
increas
express
dcsign
p
dcsignr
p
small
nonsignific
effect
figur
wherea
detect
effect
data
shown
endotheli
bind
assay
perform
use
strain
hcv
minim
interact
express
truncat
speci
flow
cytometr
detect
antibodi
rais
fail
detect
complex
flow
cytometr
analysi
hcv
bind
follow
treatment
ng
ml
hour
confirm
significantli
increas
express
ctype
lectin
led
increas
hcv
interact
stimul
hsec
red
compar
unstimul
hsec
green
control
mock
protein
black
b
hcv
bound
hsec
red
interact
inhibit
prior
incub
cell
mab
specif
dcsign
gray
dcsignr
green
line
alon
combin
blue
control
bind
mock
protein
black
determin
whether
lectin
abl
interact
high
mannosecontain
glycoprotein
test
abil
bind
truncat
version
hcv
previous
report
interact
dcsign
dcsignr
sinc
hcv
interact
viral
coreceptor
also
express
hsec
data
shown
select
strain
hcv
show
minim
interact
express
truncat
speci
detect
cellbound
mab
fail
detect
complex
express
dcsign
dcsignr
induc
concomit
increas
hcv
bind
support
cytokin
regul
function
activ
ctype
lectin
hsec
figur
hcv
bind
hsec
could
inhibit
prior
incub
cell
mab
specif
either
dcsign
dcsignr
preincub
combin
dcsign
dcsignr
mab
alter
inhibit
hcv
bind
seen
singl
mab
alon
figur
find
complet
block
antibodi
surpris
one
possibl
interpret
deriv
observ
lectin
exist
tetram
cell
surfac
find
primari
hsec
express
receptor
may
support
model
heterooligom
format
two
relat
lectin
may
explain
observ
antibodi
block
hcv
primari
cell
type
shown
previous
mab
use
studi
bind
specif
cell
transduc
express
appropri
receptor
evalu
distribut
lectin
normal
human
liver
examin
abil
dcsignand
dcsignrspecif
mab
react
cell
within
tissu
section
immunohistochemistri
stain
pattern
two
receptor
differ
dcsignr
express
within
liver
sinusoid
wherea
dcsign
detect
portal
tract
addit
hepat
sinusoid
endothelium
figur
dcsign
dcsignr
express
endotheli
cell
sinusoid
confirm
dual
stain
antibodi
select
stain
sinusoid
endotheli
cell
human
liver
figur
dcsign
express
kupffer
cell
demonstr
dual
stain
macrophag
mannos
receptorposit
cell
figur
appear
differ
intens
dcsignr
stain
across
sinusoid
bed
rel
weaker
stain
periport
sinusoid
may
reflect
differ
local
microenviron
conclus
support
observ
protein
includ
adhes
molecul
differenti
express
across
hepat
sinusoid
appropri
isotypematch
control
neg
stain
data
shown
assess
whether
dcsign
dcsignr
express
normal
liver
abl
interact
hcv
intact
liver
section
incub
truncat
bound
antigen
visual
rat
antibodi
recogn
site
henc
fail
interact
complex
bound
diffus
focal
area
within
sinusoid
bind
could
inhibit
mannan
sugar
molecul
report
interact
carbohydr
recognit
site
ctype
lectin
figur
b
confirm
ident
cell
bound
hcv
section
counterstain
mab
specif
macrophag
mannos
receptor
dcsignr
figur
b
data
confirm
hcv
interact
kupffer
sinusoid
endotheli
cell
within
liver
consist
pattern
dcsign
dcsignr
express
confirm
hcv
bind
depend
dcsign
dcsignr
express
liver
section
preincub
mab
specif
dcsign
dcsignr
evalu
abil
bind
hcv
pretreat
liver
section
control
isotypematch
mous
immunoglobulin
effect
bind
figur
mab
specif
dcsign
inhibit
bind
kupffer
sinusoid
cell
figur
wherea
mab
specif
dcsignr
attenu
bind
sinusoid
cell
figur
howev
also
use
deriv
hcv
strain
bind
high
affin
distinguish
interact
lectin
dcsign
r
use
two
mab
could
discrimin
bound
experi
allow
us
confirm
result
obtain
independ
strain
data
shown
data
conclus
show
dcsign
dcsignr
express
normal
liver
abl
interact
hcv
model
studi
hcv
interact
dcsign
dcsignr
liver
sever
investig
express
dcsign
dcsignr
heterolog
cell
system
studi
hcvpp
interact
hcvpp
fail
infect
cell
engin
express
dcsign
dcsignr
howev
infect
transfer
permiss
hepatoma
cell
suggest
lectin
molecul
may
act
transfer
receptor
within
liver
enabl
endotheli
cell
trap
concentr
hcv
within
sinusoid
transfer
viru
permiss
underli
hepatocyt
howev
assumpt
dcsigndcsignr
express
heterolog
cell
accur
mimic
primari
hsec
lectindepend
interact
hcv
undermin
recent
report
dcsign
interact
human
immunodefici
viru
depend
cellular
context
address
issu
purifi
hsec
three
donor
liver
confirm
dcsign
dcsignr
express
evalu
abil
support
hcvpp
entri
viru
entri
uncoat
quantifi
luciferas
express
target
cell
control
retrovir
promot
directli
proport
frequenc
infect
cell
pseudotyp
particl
envelop
glycoprotein
use
control
nonspecif
particl
uptak
virus
express
vesicular
stomat
viru
g
serv
control
retrovir
rna
transcript
translat
luciferas
report
gene
within
primari
cell
hcvpp
bear
strain
glycoprotein
infect
hepatoma
cell
primari
human
hepatocyt
fail
infect
hsec
figur
vesicular
stomat
viru
pseudoparticl
infect
find
demonstr
human
hsec
express
dcsignr
dcsign
vivo
receptor
interact
hcv
express
dcsign
hsec
provid
evid
abil
hsec
process
present
microbi
antigen
show
primari
hsec
unabl
support
hcvpp
hcvcc
entri
data
consist
model
dcsign
dcsignr
sinusoid
endothelium
provid
mechan
high
affin
bind
circul
hcv
within
liver
sinusoid
allow
transfer
viru
underli
hepatocyt
manner
analog
dendrit
cell
dcsign
present
hiv
lymphocyt
viral
captur
cell
surfac
rate
limit
infect
suggest
express
dcsign
dcsignr
hsec
may
enhanc
rate
effici
viru
infect
hepatocyt
express
coreceptor
scaveng
receptor
bi
dcsign
abl
recogn
highli
mannosyl
glycoprotein
surfac
broad
rang
pathogen
includ
virus
bacteria
fungi
parasit
least
agent
interact
appear
import
compon
infect
process
demonstr
human
immunodefici
viru
ebola
viru
make
dcsign
attract
target
drug
design
glycodendrit
polym
block
bind
pathogen
glycoprotein
dcsign
inhibit
dcsignmedi
infect
ebolapseudotyp
viral
model
addit
lectin
may
provid
viral
escap
mechan
uptak
hcv
dcsign
dcsignr
report
target
nonlysosom
compart
immatur
dc
wherea
lewi
x
antigen
anoth
ligand
dcsign
intern
lysosom
thu
dcsign
dcsignr
hsec
may
act
captur
hcv
blood
may
also
allow
hsec
act
reservoir
hcv
allow
viru
avoid
detect
transmit
underli
hepatocyt
primari
target
hcv
detect
function
dcsign
hsec
evid
uniqu
antigencaptur
scaveng
properti
cell
hsec
act
organresid
nonmyeloid
antigen
process
cell
crosspres
solubl
exogen
antigen
cell
use
similar
mechan
antigen
process
present
dendrit
cell
howev
outcom
crosspresent
hsec
cell
toler
major
histocompat
class
iirestrict
antigen
present
hsec
naiv
cell
lead
differenti
cell
presenc
dcsign
hsec
may
allow
cell
captur
endocytos
rang
microbi
pathogen
subsequ
present
immun
system
furthermor
dcsign
also
act
adhes
receptor
support
interact
intercellular
adhes
cell
antigen
present
dendrit
cell
transendotheli
migrat
extend
potenti
role
hsec
immun
respons
hsec
support
bind
hcv
glycoprotein
went
determin
whether
also
support
viral
infect
hsec
prepar
three
differ
liver
infect
preform
triplic
hcvpp
bear
strain
glycoprotein
infect
hepatoma
cell
fail
infect
hsec
preincub
hsec
ngml
hour
alter
result
hcvmlv
hcvno
env
serv
posit
neg
control
experi
respect
success
infect
measur
quantifi
luciferas
report
gene
express
rel
light
unit
rlu
figur
infect
cell
primari
hsec
hcvcc
cocultur
cell
primari
hsec
b
contrast
distinct
morpholog
cultur
assess
whether
primari
hsec
infect
hsec
cultur
persist
infect
cell
cell
mix
hsec
ratio
seed
cell
per
well
collagen
coat
plate
follow
day
cocultur
distinct
appear
hsec
cell
form
discret
foci
c
control
popul
cell
seed
densiti
absenc
hsec
cocultur
maintain
hour
infect
monitor
stain
hcv
antigen
viral
antigen
detect
persist
infect
cell
within
cocultur
e
viral
antigen
detect
cell
within
hsec
consist
primari
hsec
fail
support
hcvpp
infect
figur
found
increas
express
dcsign
hsec
vitro
shown
increas
express
dcsign
monocyt
cell
monocyt
treatment
favor
differenti
dendrit
cell
rather
macrophag
evid
suggest
key
cytokin
dcsign
acquisit
monocytederiv
dendrit
cell
differenti
find
provid
evid
dcsign
express
endotheli
cell
well
myeloid
cell
although
see
suppress
dcsign
treatment
report
macrophag
lack
respons
suggest
induct
dcsign
hsec
promot
rather
cytokin
respons
consist
requir
vigor
respons
clear
viral
infect
conclus
report
first
descript
dcsign
express
sinusoid
endothelium
provid
evid
uniqu
antigenprocess
scaveng
properti
cell
distinct
distribut
dcsign
dcsignr
liver
abil
lectin
bind
hcv
vivo
suggest
complementari
role
trap
hcv
within
hepat
sinusoid
upregul
dcsign
dcsignr
suggest
local
cytokin
microenviron
may
affect
hcv
cell
attach
infect
